3-(4-methylthiazol-2-yl)-4-oxo-6-propyl-4H-chromen-7-yl 2-((tert-butoxycarbonyl)amino)acetate
TL;DR: 3-(4-methylthiazol-2-yl)-4-oxo-6-propyl-4H-chromen-7-yl 2-((tert-butoxycarbonyl)amino)acetate (CAS 374702-39-3) is a chemical compound with molecular formula C23H26N2O6S and molecular weight 458.15 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
[3-(4-methyl-1,3-thiazol-2-yl)-4-oxo-6-propylchromen-7-yl] 2-[(2-methylpropan-2-yl)oxycarbonylamino]acetate
Also Known As: 3-(4-methylthiazol-2-yl)-4-oxo-6-propyl-4H-chromen-7-yl 2-((tert-butoxycarbonyl)amino)acetate, [3-(4-methyl-1,3-thiazol-2-yl)-4-oxo-6-propylchromen-7-yl] 2-[(2-methylpropan-2-yl)oxycarbonylamino]acetate, 3-(4-methyl-1,3-thiazol-2-yl)-4-oxo-6-propyl-4H-chromen-7-yl N-(tert-butoxycarbonyl)glycinate
| Molecular Formula | C23H26N2O6S |
|---|---|
| Molecular Weight | 458.15 g/mol |
| LogP | 4.60752 |
| Topological Polar Surface Area | 107.73 Ų |
| Hydrogen Bond Donors | 1 |
| Hydrogen Bond Acceptors | 8 |
| Rotatable Bonds | 6 |
| Exact Mass | 458.15115 |
| Heavy Atoms | 32 |
| Complexity | 1205.3975 |
Chemical Identifiers
| CAS Number | 374702-39-3 |
|---|---|
| SMILES | CCCC1=CC2=C(C=C1OC(=O)CNC(=O)OC(C)(C)C)OC=C(C2=O)C3=NC(=CS3)C |
Product Overview
3-(4-methylthiazol-2-yl)-4-oxo-6-propyl-4H-chromen-7-yl 2-((tert-butoxycarbonyl)amino)acetate (CAS 374702-39-3), with molecular formula C23H26N2O6S and molecular weight 458.15 g/mol. IUPAC: [3-(4-methyl-1,3-thiazol-2-yl)-4-oxo-6-propylchromen-7-yl] 2-[(2-methylpropan-2-yl)oxycarbonylamino]acetate.
Chemical Property Profile of 3-(4-methylthiazol-2-yl)-4-oxo-6-propyl-4H-chromen-7-yl 2-((tert-butoxycarbonyl)amino)acetate
Property Insights of 3-(4-methylthiazol-2-yl)-4-oxo-6-propyl-4H-chromen-7-yl 2-((tert-butoxycarbonyl)amino)acetate
The XLogP value of 4.60752 indicates that 3-(4-methylthiazol-2-yl)-4-oxo-6-propyl-4H-chromen-7-yl 2-((tert-butoxycarbonyl)amino)acetate is lipophilic (fat-soluble), which may influence its absorption, distribution, and formulation strategy. The TPSA of 107.73 Ų falls within the moderate polarity range, balancing permeability and solubility for 3-(4-methylthiazol-2-yl)-4-oxo-6-propyl-4H-chromen-7-yl 2-((tert-butoxycarbonyl)amino)acetate. Following Lipinski's Rule of Five, 3-(4-methylthiazol-2-yl)-4-oxo-6-propyl-4H-chromen-7-yl 2-((tert-butoxycarbonyl)amino)acetate has 1 hydrogen bond donor(s) and 8 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of 3-(4-methylthiazol-2-yl)-4-oxo-6-propyl-4H-chromen-7-yl 2-((tert-butoxycarbonyl)amino)acetate?
The CAS number of 3-(4-methylthiazol-2-yl)-4-oxo-6-propyl-4H-chromen-7-yl 2-((tert-butoxycarbonyl)amino)acetate is 374702-39-3.
What is the molecular formula of 3-(4-methylthiazol-2-yl)-4-oxo-6-propyl-4H-chromen-7-yl 2-((tert-butoxycarbonyl)amino)acetate?
The molecular formula of 3-(4-methylthiazol-2-yl)-4-oxo-6-propyl-4H-chromen-7-yl 2-((tert-butoxycarbonyl)amino)acetate is C23H26N2O6S.
What is the molecular weight of 3-(4-methylthiazol-2-yl)-4-oxo-6-propyl-4H-chromen-7-yl 2-((tert-butoxycarbonyl)amino)acetate?
The molecular weight of 3-(4-methylthiazol-2-yl)-4-oxo-6-propyl-4H-chromen-7-yl 2-((tert-butoxycarbonyl)amino)acetate is 458.15 g/mol.
Where can I buy 3-(4-methylthiazol-2-yl)-4-oxo-6-propyl-4H-chromen-7-yl 2-((tert-butoxycarbonyl)amino)acetate?
You can request a quote for 3-(4-methylthiazol-2-yl)-4-oxo-6-propyl-4H-chromen-7-yl 2-((tert-butoxycarbonyl)amino)acetate directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for 3-(4-methylthiazol-2-yl)-4-oxo-6-propyl-4H-chromen-7-yl 2-((tert-butoxycarbonyl)amino)acetate?
Yes, KEHONG BIO provides custom synthesis services for 3-(4-methylthiazol-2-yl)-4-oxo-6-propyl-4H-chromen-7-yl 2-((tert-butoxycarbonyl)amino)acetate and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.